Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:bilateral testis tumor incidence/prevalence measurement
go back to main search page
Accession:CMO:0001263 term browser browse the term
Definition:Any measurement in which the number of individuals in a study population that display tumors in both testes at a point in time or develop tumors in both testes within a determined period of time are compared to the total number of individuals in the study population. Often expressed as a percentage but could be expressed as a ratio.



show annotations for term's descendants           Sort by:

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    tumor measurement 88
      tumor incidence/prevalence measurement 16
        testis tumor incidence/prevalence measurement 1
          bilateral testis tumor incidence/prevalence measurement 0
            percentage of study population developing bilateral testis tumors during a period of time 0
            percentage of study population displaying bilateral testis tumors at a point in time 0
Path 2
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        organ tumorous lesion measurement 108
          testis tumorous lesion measurement 1
            testis tumor measurement 1
              testis tumor incidence/prevalence measurement 1
                bilateral testis tumor incidence/prevalence measurement 0
                  percentage of study population developing bilateral testis tumors during a period of time 0
                  percentage of study population displaying bilateral testis tumors at a point in time 0
paths to the root